Filing Details
- Accession Number:
- 0001237899-20-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-25 16:05:36
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-25 16:05:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226690 | George Yancopoulos | 777 Old Saw Mill River Road Tarrytown NY 10591 | President And Chief Scientific | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-24 | 118,123 | $420.17 | 517,799 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,791 | Indirect | By 401(k) Plan |
Common Stock | 57,465 | Indirect | by 2018 GRAT |
Common Stock | 500,000 | Indirect | by 2019 GRAT |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 118,123 shares of Company stock on February 24, 2020 at prices ranging from $420.00 to $420.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 24, 2020 at each separate price.